Cooper Long Term Debt 2010-2024 | COO

Cooper long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Cooper long term debt for the quarter ending July 31, 2024 was $2.592B, a 3.06% increase year-over-year.
  • Cooper long term debt for 2023 was $2.524B, a 7.36% increase from 2022.
  • Cooper long term debt for 2022 was $2.351B, a 68.2% increase from 2021.
  • Cooper long term debt for 2021 was $1.398B, a 0.99% increase from 2020.
Cooper Annual Long Term Debt
(Millions of US $)
2023 $2,524
2022 $2,351
2021 $1,398
2020 $1,384
2019 $1,263
2018 $1,986
2017 $1,149
2016 $1,107
2015 $1,105
2014 $1,281
2013 $302
2012 $348
2011 $327
2010 $592
2009 $772
Cooper Quarterly Long Term Debt
(Millions of US $)
2024-07-31 $2,592
2024-04-30 $2,671
2024-01-31 $2,726
2023-10-31 $2,524
2023-07-31 $2,515
2023-04-30 $2,566
2023-01-31 $2,627
2022-10-31 $2,351
2022-07-31 $2,347
2022-04-30 $2,347
2022-01-31 $2,347
2021-10-31 $1,398
2021-07-31 $1,180
2021-04-30 $1,325
2021-01-31 $1,414
2020-10-31 $1,384
2020-07-31 $1,328
2020-04-30 $1,345
2020-01-31 $1,234
2019-10-31 $1,263
2019-07-31 $1,423
2019-04-30 $1,472
2019-01-31 $1,687
2018-10-31 $1,986
2018-07-31 $2,249
2018-04-30 $2,442
2018-01-31 $2,373
2017-10-31 $1,149
2017-07-31 $1,180
2017-04-30 $1,346
2017-01-31 $1,201
2016-10-31 $1,107
2016-07-31 $1,412
2016-04-30 $1,411
2016-01-31 $1,331
2015-10-31 $1,105
2015-07-31 $1,070
2015-04-30 $1,106
2015-01-31 $1,303
2014-10-31 $1,281
2014-07-31 $301
2014-04-30 $302
2014-01-31 $302
2013-10-31 $302
2013-07-31 $215
2013-04-30 $292
2013-01-31 $378
2012-10-31 $348
2012-07-31 $454
2012-04-30 $275
2012-01-31 $371
2011-10-31 $327
2011-07-31 $406
2011-04-30 $524
2011-01-31 $587
2010-10-31 $592
2010-07-31 $624
2010-04-30 $699
2010-01-31 $724
2009-10-31 $772
2009-07-31 $801
2009-04-30 $848
2009-01-31 $871
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.075B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.108B 21.59
Becton Dickinson (BDX) United States $64.746B 17.02
Cardinal Health (CAH) United States $29.487B 15.99
West Pharmaceutical Services (WST) United States $22.928B 46.83
Labcorp (LH) United States $20.046B 16.62
Align Technology (ALGN) United States $16.863B 32.27
Henry Schein (HSIC) United States $9.361B 17.83
Merit Medical Systems (MMSI) United States $6.139B 31.35
DENTSPLY SIRONA (XRAY) United States $3.731B 10.15
CONMED (CNMD) United States $2.314B 19.31
Patterson (PDCO) United States $1.803B 9.52
STAAR Surgical (STAA) United States $1.315B 48.51
Lifevantage (LFVN) United States $0.178B 23.67
Pro-Dex (PDEX) United States $0.152B 30.36